Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Haixi Pharmaceuticals Co. Ltd.

Latest From Haixi Pharmaceuticals Co. Ltd.

Meet China’s New Innovators: UStar Biotech Makes Molecular Testing Available Under A Tree

Low costs and mass manufacturing are enabling Chinese innovators to expand access to onsite diagnostics in the developing world, aided by organizations such as the Bill and Melinda Gates Foundation.

Medical Device China

Where Is The Sharpest Drug Growth In China’s Hospitals?

According to a new report from McKinsey, pharmaceutical sales in large hospitals are growing rapidly and multinational companies are holding their own against domestic companies in their “core” markets. But the oncology space could see fiercer competition as local companies emerge to compete with multinationals.

BioPharmaceutical China

Emerging Company In An Emerging Market: Generon Sees Quality And Price As Litmus Test

Generon in Shanghai was founded by former Hutchison MediPharma employees to target a niche market between expensive import drugs and lower quality domestic products.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Haixi Pharmaceuticals Co. Ltd.
  • Senior Management
  • Jason Xinshan Kang, PhD, CEO
  • Contact Info
  • Haixi Pharmaceuticals Co. Ltd.
    Phone: 591 87519936
    20 N. Jinzhou, Jinshan Industrial Park
    Cangshan Dist.
    Fuzhou, 350002